• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Discussion 1: The Role of Consumerism in Deliverability of Care

Article

Cliff Goodman, PhD, senior vice president and principal at the Lewin Group, kicks off the first discussion of AJMC's PCOC 2013 by introducing panelists Amy Berman, BS, RN, Dennis Scanlon, PhD, and Manasi A. Tirodkar, PhD, MS, as they consider the role of consumerism in deliverability of care.

Cliff Goodman, PhD, senior vice president and principal at the Lewin Group, kicks off the first discussion of AJMC’s PCOC 2013 by introducing panelists Amy Berman, BS, RN, Dennis Scanlon, PhD, and Manasi A. Tirodkar, PhD, MS, as they consider the role of consumerism in deliverability of care.

The panelists weigh in on issues and trends as they relate to patient engagement. This includes copayments, outcomes, sites of care, new insurance plans, and how to enhance consumerism. Upon Dr Goodman asking the panelists how they would enhance the role of the informed patient/consumer in rocky economic conditions, responses varied.

“You said ‘How are we going to force consumerism?’, and I think that is the wrong question,” says Ms Berman. “Consumerism has arrived. Consumerism is here. I think fundamentally people are going to demand certain things.”

“Patients need navigation, support, and logistical support,” adds Dr Mansai. ”Different places, different people provide those functions. It could be a nurse navigator, patient navigator, care coordinator—there are various different people that can fulfill that role [who] can also provide that information on finances and navigating payer systems and reimbursement.”

“I think the economics are interesting and challenging, because when we talk about insurance enrollment there’s a lot of incentives, particularly for reasonably healthy people to think about, or potentially discount, high deductible plans,” answers Dr Scanlon. “What they buy now, might have strong implication for their future.”

Related Videos
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Pamela J. McShane, MD, an expert on bronchiectasis
"Integrating New PAH Therapies into Clinical Practice"
Julie Patterson, PharmD, PhD
"Clinical Evidence for Emerging PAH Therapies"
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Dr Chris Pagnani
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.